The French National Medicines Safety Agency (ANSM) has officially stated that flowers will not be incorporated into its forthcoming comprehensive medical cannabis framework. Although somewhat anticipated, the sudden decision and the ANSM’s failure to propose any feasible alternatives for patients reliant on cannabis flower have triggered widespread outrage.